{"id":4822,"date":"2012-05-02T12:30:52","date_gmt":"2012-05-02T16:30:52","guid":{"rendered":"https:\/\/themedicalxchange.com\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/"},"modified":"2021-09-13T17:41:46","modified_gmt":"2021-09-13T21:41:46","slug":"64e-congres-annuel-de-lamerican-academy-of-neurolo","status":"publish","type":"post","link":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/","title":{"rendered":"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient"},"content":{"rendered":"<p>Les trois anticonvulsivants reconnus efficaces dans les lignes directrices r\u00e9cemment publi\u00e9es (Silberstein, S. D., <em>et\u00a0al<\/em>. <em>Neurology<\/em>, vol.\u00a078, n<sup>o<\/sup>\u00a017,2012, p.\u00a01337-1345) sont le divalproex de sodium, le valproate de sodium et le topiramate. Les \u00df-bloquants mentionn\u00e9s sont le propranolol et le m\u00e9toprolol; quant au triptan en question, il s\u2019agit du frovatriptan. Ces lignes directrices comportent parall\u00e8lement de longues listes de m\u00e9dicaments class\u00e9s dans d\u2019autres cat\u00e9gories telles que \u00ab\u00a0probablement efficaces\u00a0\u00bb, \u00ab\u00a0possiblement efficaces\u00a0\u00bb et \u00ab\u00a0donn\u00e9es insuffisantes ou contradictoires\u00a0\u00bb. Seulement un agent, le lamitrog\u00e8ne, un anticonvulsivant, a \u00e9t\u00e9 d\u00e9clar\u00e9 inefficace \u00e0 la lumi\u00e8re des r\u00e9sultats d\u2019au moins deux essais comparatifs multicentriques et certaines donn\u00e9es issues d\u2019essais cliniques portent aussi \u00e0 croire que la clomipramine est probablement inefficace. En outre, plusieurs agents ont \u00e9t\u00e9 class\u00e9s dans la cat\u00e9gorie \u00ab\u00a0possiblement inefficaces\u00a0\u00bb suivant les r\u00e9sultats n\u00e9gatifs obtenus lors d\u2019\u00e9tudes men\u00e9es chez de petits effectifs de sujets. Cette recherche documentaire rigoureuse et la r\u00e9daction des lignes directrices qui en a d\u00e9coul\u00e9 ont pour objectif, entre autres, de raffermir la confiance des prescripteurs envers les traitements pr\u00e9ventifs, puisqu\u2019ils semblent sous-utilis\u00e9s. La migraine \u00e9tant d\u00e9bilitante pour beaucoup de patients, bien souvent il vaut mieux pr\u00e9venir que gu\u00e9rir, selon le D<sup>r<\/sup>\u00a0Stephen\u00a0D.\u00a0Silberstein, du Jefferson Headache Center, de la Thomas Jefferson University, de Philadelphie, en Pennsylvanie. Le D<sup>r<\/sup>\u00a0Silberstein pr\u00e9cise que pr\u00e8s de 40\u00a0% des patients aux prises avec des migraines r\u00e9cidivantes devraient envisager de suivre un traitement prophylactique, mais que selon les estimations, seulement le tiers de ceux auxquels ces strat\u00e9gies pourraient convenir le font. \u00ab\u00a0La prophylaxie convient particuli\u00e8rement aux patients qui ont des crises de migraine persistante, associ\u00e9e \u00e0 de la faiblesse ou \u00e0 d\u2019autres sympt\u00f4mes neurologiques susceptibles de pr\u00e9senter des risques ou un certain danger\u00a0\u00bb, a affirm\u00e9 le D<sup>r<\/sup>\u00a0Silberstein. Apr\u00e8s avoir ajout\u00e9 que le recours aux traitements pr\u00e9ventifs peut avoir d\u2019autres motivations, comme la pr\u00e9f\u00e9rence des patients, il a tenu \u00e0 souligner que ces lignes directrices n\u2019ont pas pour objectif de dissuader les m\u00e9decins d\u2019utiliser les m\u00e9dicaments qui ne sont pas inscrits sur la liste des produits dont l\u2019efficacit\u00e9 a \u00e9t\u00e9 \u00e9prouv\u00e9e. Elles visent plut\u00f4t \u00e0 fournir aux m\u00e9decins et \u00e0 leurs patients une appr\u00e9ciation plus structur\u00e9e des donn\u00e9es probantes \u00e0 l\u2019appui des divers produits en jaugeant la qualit\u00e9 de ces derni\u00e8res. \u00ab\u00a0Nous avons cherch\u00e9 \u00e0 \u00e9valuer dans quelle mesure les donn\u00e9es probantes \u00e0 l\u2019appui d\u2019un produit sont de bonne qualit\u00e9 et non pas \u00e0 d\u00e9terminer si un m\u00e9dicament est efficace ou non\u00a0\u00bb, a soutenu le D<sup>r<\/sup>\u00a0Silberstein. Cette nuance est particuli\u00e8rement pertinente, l\u2019h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 de la r\u00e9ponse des patients \u00e0 un m\u00e9dicament faisant en sorte qu\u2019un m\u00e9dicament peut \u00eatre extr\u00eamement efficace chez l\u2019un et tr\u00e8s peu chez l\u2019autre. Qui plus est, le contexte clinique est important. En effet, au cours d\u2019aucun de ces essais a-t-on vu des femmes en \u00e2ge de procr\u00e9er recevoir des m\u00e9dicaments dont l\u2019innocuit\u00e9 durant la grossesse n\u2019avait pas \u00e9t\u00e9 \u00e9tablie. Admettant que bien des m\u00e9dicaments offerts sur le march\u00e9 sont possiblement efficaces hormis ceux qui ont \u00e9t\u00e9 \u00e9num\u00e9r\u00e9s dans les lignes directrices, le D<sup>r<\/sup>\u00a0Silberstein pr\u00e9cise que ces lignes directrices factuelles constituent simplement un \u00e9tat des lieux de la litt\u00e9rature portant sur la migraine. <a href=\"javascript:void(0)\" class=\"show-image\" data-index=\"0\">(Tableau 1)<\/a> \u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p><b> Nouvelle-Orl\u00e9ans <\/b> \u2013 Selon les derni\u00e8res lignes directrices \u00e9mises conjointement par l\u2019American Academy of Neurology (AAN) et l\u2019American Headache Society (AHS), seulement six des nombreux m\u00e9dicaments qui ont \u00e9t\u00e9 \u00e9tudi\u00e9s pour la pr\u00e9vention de la migraine ont \u00e9t\u00e9 reconnus comme vraiment efficaces, soit trois anticonvulsivants, deux \u00df-bloquants et un triptan. Cela ne signifie pas que les autres agents sont inefficaces, mais ces six produits sont les seuls qui, au terme d\u2019une recherche documentaire rigoureuse, se sont r\u00e9v\u00e9l\u00e9s efficaces lors d\u2019au moins deux essais comparatifs multicentriques.<\/p>\n","protected":false},"author":1,"featured_media":4823,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"tags":[408,413,523,524,287,662],"class_list":["post-4822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-2012-fr","tag-aan-fr","tag-extract-fr","tag-migraine-fr","tag-neurologie","tag-neurology-fr","area_tag-neurologie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient - The Medical Xchange<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient - The Medical Xchange\" \/>\n<meta property=\"og:description\" content=\"Nouvelle-Orl\u00e9ans \u2013 Selon les derni\u00e8res lignes directrices \u00e9mises conjointement par l\u2019American Academy of Neurology (AAN) et l\u2019American Headache Society (AHS), seulement six des nombreux m\u00e9dicaments qui ont \u00e9t\u00e9 \u00e9tudi\u00e9s pour la pr\u00e9vention de la migraine ont \u00e9t\u00e9 reconnus comme vraiment efficaces, soit trois anticonvulsivants, deux \u00df-bloquants et un triptan. Cela ne signifie pas que les autres agents sont inefficaces, mais ces six produits sont les seuls qui, au terme d\u2019une recherche documentaire rigoureuse, se sont r\u00e9v\u00e9l\u00e9s efficaces lors d\u2019au moins deux essais comparatifs multicentriques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/\" \/>\n<meta property=\"og:site_name\" content=\"The Medical Xchange\" \/>\n<meta property=\"article:published_time\" content=\"2012-05-02T16:30:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-13T21:41:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2012\/05\/EX_7002_AAN_Tableau_1_FR.PNG\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"nuagelab\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"nuagelab\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/\"},\"author\":{\"name\":\"nuagelab\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/c4e17cbf7de41a40b9366989481cfc4b\"},\"headline\":\"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient\",\"datePublished\":\"2012-05-02T16:30:52+00:00\",\"dateModified\":\"2021-09-13T21:41:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/\"},\"wordCount\":616,\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2012\\\/05\\\/EX_7002_AAN_Tableau_1_FR.PNG\",\"keywords\":[\"2012\",\"AAN\",\"extract\",\"migraine\",\"neurologie\",\"neurology\"],\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/\",\"name\":\"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient - The Medical Xchange\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2012\\\/05\\\/EX_7002_AAN_Tableau_1_FR.PNG\",\"datePublished\":\"2012-05-02T16:30:52+00:00\",\"dateModified\":\"2021-09-13T21:41:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/c4e17cbf7de41a40b9366989481cfc4b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2012\\\/05\\\/EX_7002_AAN_Tableau_1_FR.PNG\",\"contentUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2012\\\/05\\\/EX_7002_AAN_Tableau_1_FR.PNG\",\"width\":960,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2012\\\/05\\\/02\\\/64e-congres-annuel-de-lamerican-academy-of-neurolo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\",\"name\":\"The Medical Xchange\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/c4e17cbf7de41a40b9366989481cfc4b\",\"name\":\"nuagelab\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4264331b8ad626daf710d626ffc98eb71b9ccc45de1c39ed9511f9f5af72d645?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4264331b8ad626daf710d626ffc98eb71b9ccc45de1c39ed9511f9f5af72d645?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4264331b8ad626daf710d626ffc98eb71b9ccc45de1c39ed9511f9f5af72d645?s=96&d=mm&r=g\",\"caption\":\"nuagelab\"},\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/author\\\/nuagelab\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient - The Medical Xchange","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/","og_locale":"fr_FR","og_type":"article","og_title":"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient - The Medical Xchange","og_description":"Nouvelle-Orl\u00e9ans \u2013 Selon les derni\u00e8res lignes directrices \u00e9mises conjointement par l\u2019American Academy of Neurology (AAN) et l\u2019American Headache Society (AHS), seulement six des nombreux m\u00e9dicaments qui ont \u00e9t\u00e9 \u00e9tudi\u00e9s pour la pr\u00e9vention de la migraine ont \u00e9t\u00e9 reconnus comme vraiment efficaces, soit trois anticonvulsivants, deux \u00df-bloquants et un triptan. Cela ne signifie pas que les autres agents sont inefficaces, mais ces six produits sont les seuls qui, au terme d\u2019une recherche documentaire rigoureuse, se sont r\u00e9v\u00e9l\u00e9s efficaces lors d\u2019au moins deux essais comparatifs multicentriques.","og_url":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/","og_site_name":"The Medical Xchange","article_published_time":"2012-05-02T16:30:52+00:00","article_modified_time":"2021-09-13T21:41:46+00:00","og_image":[{"width":960,"height":720,"url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2012\/05\/EX_7002_AAN_Tableau_1_FR.PNG","type":"image\/png"}],"author":"nuagelab","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"nuagelab","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/#article","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/"},"author":{"name":"nuagelab","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/c4e17cbf7de41a40b9366989481cfc4b"},"headline":"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient","datePublished":"2012-05-02T16:30:52+00:00","dateModified":"2021-09-13T21:41:46+00:00","mainEntityOfPage":{"@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/"},"wordCount":616,"image":{"@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2012\/05\/EX_7002_AAN_Tableau_1_FR.PNG","keywords":["2012","AAN","extract","migraine","neurologie","neurology"],"articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/","url":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/","name":"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient - The Medical Xchange","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/#primaryimage"},"image":{"@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2012\/05\/EX_7002_AAN_Tableau_1_FR.PNG","datePublished":"2012-05-02T16:30:52+00:00","dateModified":"2021-09-13T21:41:46+00:00","author":{"@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/c4e17cbf7de41a40b9366989481cfc4b"},"breadcrumb":{"@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/#primaryimage","url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2012\/05\/EX_7002_AAN_Tableau_1_FR.PNG","contentUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2012\/05\/EX_7002_AAN_Tableau_1_FR.PNG","width":960,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/themedicalxchange.com\/fr\/2012\/05\/02\/64e-congres-annuel-de-lamerican-academy-of-neurolo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/themedicalxchange.com\/en\/"},{"@type":"ListItem","position":2,"name":"De nouvelles lignes directrices sur la migraine classent de nombreux m\u00e9dicaments en fonction de la qualit\u00e9 des donn\u00e9es probantes qui les appuient"}]},{"@type":"WebSite","@id":"https:\/\/themedicalxchange.com\/en\/#website","url":"https:\/\/themedicalxchange.com\/en\/","name":"The Medical Xchange","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/themedicalxchange.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/c4e17cbf7de41a40b9366989481cfc4b","name":"nuagelab","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/4264331b8ad626daf710d626ffc98eb71b9ccc45de1c39ed9511f9f5af72d645?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4264331b8ad626daf710d626ffc98eb71b9ccc45de1c39ed9511f9f5af72d645?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4264331b8ad626daf710d626ffc98eb71b9ccc45de1c39ed9511f9f5af72d645?s=96&d=mm&r=g","caption":"nuagelab"},"url":"https:\/\/themedicalxchange.com\/fr\/author\/nuagelab\/"}]}},"_links":{"self":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/posts\/4822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/comments?post=4822"}],"version-history":[{"count":0,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/posts\/4822\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/media\/4823"}],"wp:attachment":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/media?parent=4822"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/tags?post=4822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}